A clinical trail to study ondansetron on reducing drop in blood pressure after spinal anaesthesia.
Not Applicable
Completed
- Conditions
- Health Condition 1: - Health Condition 2: null- patients without any comorbid diseases
- Registration Number
- CTRI/2018/04/013190
- Lead Sponsor
- Dr Geetha CR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 140
Inclusion Criteria
American Society of Anaesthesiologists (ASA) grade I-II
Exclusion Criteria
1 Patients in whom spinal anaesthesia is contraindicated.
2 Patients having known allergy to ondansetron.
3 Patients having hypertension and coronary artery disease.
4 Patients who are taking selective serotonin reuptake inhibitors (SSRI).
5 Parturients
6 Patients having Autonomic Neuropathy.
7 BMI > 30 kg/m2.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of intravenous ondansetron on spinal anaesthesia induced hypotension and bradycardia.Timepoint: 0min, 3mins ,6mins, 9mins, 12 mins, 15mins, 18mins, 21mins, 24mins, 27mins, 30mins.
- Secondary Outcome Measures
Name Time Method 1) Peri-operative nausea, vomiting. <br/ ><br>2) Shivering. <br/ ><br>Timepoint: 30 mins, 60 mins